Company / Free Cash Flow
Neogen Free Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$46.4M
FY2024
5-year range
-$76.2M / $43.6M
FY2020-FY2024
Trend
+39.1%
vs FY2023
Sector context
#126 of 145
Health Care
What the data says
Neogen's free cash flow of -$46M is lower than 87% of companies in the Health Care sector (FY2024). Free Cash Flow returned to growth in FY2024 after 4 years of decline, reaching -$46M.
Based on SEC 10-K filings.
-$46M in FY2024.
Declined from -$25M to -$46M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 145This company -$46.4M Sector average $770.9M
▼
-106.0% below sector average
Key checks
Key Insights
- In FY2024, free cash flow increased 39.1% year-over-year.
- Ranks #126 out of 145 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$46.4M | +39.1% |
| FY2023 | -$76.2M | -208.0% |
| FY2022 | -$24.7M | -156.7% |
| FY2021 | $43.6M | -19.8% |
| FY2020 | $54.4M | -12.0% |
| FY2019 | $61.8M | +25.7% |
| FY2018 | $49.2M | +2.1% |
| FY2017 | $48.2M | +5.4% |
| FY2016 | $45.7M | +116.5% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026